May 11, 2026 Sweden
Diamyd Medical receives positive feedback from the Swedish Medical Products Agency
In an interview with BioStock, Sofia Mayans, Head of Manufacturing Site at Diamyd Medical, commented on the positive feedback received from the Swedish Medical Products Agency after an inspection of the company’s Umeå facility. The inspection brings Diamyd Medical closer to GMP certification and a manufacturing license for its recombinant protein platform. The company also sees potential future opportunities in partnerships, CDMO services, and licensing.
Read the article here
Information presented here are not press releases and may include excerpts from and links to externally published content. Diamyd Medical is not responsible for externally published content.